Orchard Therapeutics Investors

35 investors on Angel Roster list Orchard Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and Singapore.

Investors are matched on the company name in their portfolio, so companies that share the name Orchard Therapeutics can appear together.

Investors listed
35
With verified email
49%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 35 Orchard Therapeutics investors

The most complete profiles first. Showing 35 of 35.

  • Brett ZbarVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more

    Verified email available

  • Bryan RobertsVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareTelecommunicationsWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Cloudflare, Adavium and 82 more

    Verified email available

  • Dennis RyanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Dorothy MargolskeeVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Ethan BatraskiVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareRemote Work TechTelecommunications

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 66 more

    Verified email available

  • Geeta VemuriVerified

    Venture Capital, Founder, Private Equity Firm · United States

    Series AHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Entrada Therapeutics, Orchard Therapeutics, Skyhawk Therapeutics, Aptinyx and 12 more

    Verified email available

  • Harry BarberVerified

    Venture Capital, Investor · United States

    Series BSeries AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Joshua KennedyVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Verified email available

  • Matt TaylorVerified

    Venture Capital, Advisor, Private Equity Firm · United Kingdom

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Nimish ShahVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Rhonda KaufmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedLife Science

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Verified email available

  • Stephanie A. SirotaVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsEnterprise SoftwareInvestment Management

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Verified email available

  • Todd GrahamVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Natalie JohnstonVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more

    Verified email available

  • Owen SmithVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more

    Verified email available

  • Alex RosenVerified

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Andrew Gottesdiener

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Luke Bagaason, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Megan Blewett

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Naveen Yalamanchi

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Piratip Pratumsuwan

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more

    Contact details available

  • Preston Noon

    Venture Capital, Private Equity Firm, Micro VC · United States

    Series AHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Entrada Therapeutics, Orchard Therapeutics, Skyhawk Therapeutics, Aptinyx and 9 more

    Contact details available

  • Richard Lau, CFA

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more

    Contact details available

  • Roderick Wong

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more

    Contact details available

  • Sabera Loughran

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Tony Nguyen

    Hedge Fund, Venture Capital, Investor · United States

    Series BAdvertisingHealth CareGeneticsInvestment Management

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Kieran Mudryy

    Venture Capital, Private Equity Firm, Investor · Singapore

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Mike Tyrrell

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Paul Dossa

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Andrey Kozlov

    Venture Capital · United Kingdom

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more

    Contact details available

  • Vasily Fedorin

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more

    Contact details available

  • Simone Song

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Pillar Biosciences, Orchard Therapeutics, Enable Injections, Arterys and 3 more

    Contact details available

Frequently asked questions

How many Orchard Therapeutics investors are on Angel Roster?

Angel Roster lists 35 Orchard Therapeutics investors. 17 of them (49%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (33), Private Equity Firms (16) and Hedge Funds (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Orchard Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (12), Series B (10) and Series A (8).

Where are Orchard Therapeutics investors based?

Most are based in the United States (28), the United Kingdom (5) and Singapore (1).

Which companies have Orchard Therapeutics investors backed?

The most-backed portfolio companies among them are Keros Therapeutics (17), Olema Oncology (17), Encoded Therapeutics (17), Element Biosciences (17) and VelosBio (17).

How do I contact Orchard Therapeutics investors?

Create a free Angel Roster account to search and filter all 35, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.